- Xebra Brands (CSE:XBRA) has revealed it has completed the first manufacturing run of its Elements line
- The authorization for importation, launch and sale of the Elements line was granted to Elements Bioscience SAPI de C.V., a subsidiary of the company, by Mexican regulatory authorities
- This represents a crucial step in Xebra Brands’ initial distribution efforts in Mexico
- Shares of Xebra Brands are unchanged at C$0.10
Xebra Brands (CSE:XBRA) has revealed it has completed the first manufacturing run of its Elements line.
The company stated in a news release that the authorization for importation, launch and sale of the Elements line was granted to Elements Bioscience SAPI de C.V., a subsidiary of the company, by Mexican regulatory authorities.
This represents a crucial step in Xebra Brands’ initial distribution efforts in Mexico.
The Elements CBD brand includes capsules, tinctures, topicals and intimate oils.
With the launch of the brand, Xebra Brands is poised to capitalize on the growing demand of these products as the only legal company that has been granted authorization to domestically produce and sell CBD prducts in Mexico.
With headquarters out of Vancouver, Xebra Brands is a cannabis company dedicated to providing high-quality, innovative products to consumers worldwide and is a first mover in the Mexican cannabis sector and the only company legally allowed to cultivate, manufacture, operate and sell cannabis in Mexico.
Shares of Xebra Brands (CSE:XBRA) are unchanged at C$0.10.
Join the discussion: Find out what everybody’s saying about this stock on the Xebra Brands Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top image: Adobe Stock)
